iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC decreased its stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) by 4.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 23,541 shares of the company’s stock after selling 1,069 shares during the period. Mutual of America Capital Management LLC’s holdings in iRhythm Technologies were worth $2,520,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Bradley Mark J. boosted its stake in iRhythm Technologies by 0.5% during the 4th quarter. Bradley Mark J. now owns 21,625 shares of the company’s stock worth $2,025,000 after purchasing an additional 110 shares during the period. Campbell & CO Investment Adviser LLC boosted its stake in iRhythm Technologies by 1.4% during the 3rd quarter. Campbell & CO Investment Adviser LLC now owns 10,059 shares of the company’s stock worth $948,000 after purchasing an additional 137 shares during the period. US Bancorp DE boosted its stake in iRhythm Technologies by 3.7% during the 1st quarter. US Bancorp DE now owns 4,012 shares of the company’s stock worth $632,000 after purchasing an additional 144 shares during the period. Ensign Peak Advisors Inc boosted its stake in iRhythm Technologies by 1.6% during the 1st quarter. Ensign Peak Advisors Inc now owns 9,530 shares of the company’s stock worth $1,182,000 after purchasing an additional 150 shares during the period. Finally, Baird Financial Group Inc. boosted its stake in iRhythm Technologies by 1.1% during the 4th quarter. Baird Financial Group Inc. now owns 17,649 shares of the company’s stock worth $1,653,000 after purchasing an additional 197 shares during the period.

iRhythm Technologies Stock Down 0.0 %

Shares of iRhythm Technologies stock opened at $112.09 on Friday. The company has a market cap of $3.49 billion, a P/E ratio of -27.68 and a beta of 1.30. The company has a debt-to-equity ratio of 0.17, a quick ratio of 2.02 and a current ratio of 2.15. iRhythm Technologies, Inc. has a one year low of $70.24 and a one year high of $140.23. The firm has a fifty day moving average of $111.45 and a two-hundred day moving average of $101.20.

iRhythm Technologies (NASDAQ:IRTC) last announced its quarterly earnings results on Thursday, February 22nd. The company reported ($1.26) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.66). The company had revenue of $132.51 million during the quarter, compared to analysts’ expectations of $131.14 million. iRhythm Technologies had a negative net margin of 25.05% and a negative return on equity of 56.38%. On average, analysts forecast that iRhythm Technologies, Inc. will post -3.14 earnings per share for the current year.

Insider Activity

In other news, CEO Quentin S. Blackford sold 24,701 shares of the stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $121.96, for a total value of $3,012,533.96. Following the completion of the transaction, the chief executive officer now owns 180,015 shares in the company, valued at approximately $21,954,629.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other iRhythm Technologies news, insider Patrick Michael Murphy sold 7,615 shares of the firm’s stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $121.96, for a total transaction of $928,725.40. Following the completion of the transaction, the insider now directly owns 48,962 shares in the company, valued at approximately $5,971,405.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Quentin S. Blackford sold 24,701 shares of the firm’s stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $121.96, for a total transaction of $3,012,533.96. Following the transaction, the chief executive officer now owns 180,015 shares of the company’s stock, valued at $21,954,629.40. The disclosure for this sale can be found here. Insiders sold 35,052 shares of company stock worth $4,274,942 in the last 90 days. 0.43% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Truist Financial increased their price target on shares of iRhythm Technologies from $115.00 to $133.00 and gave the stock a “buy” rating in a research note on Friday, December 22nd. JPMorgan Chase & Co. decreased their price target on shares of iRhythm Technologies from $142.00 to $133.00 and set an “overweight” rating for the company in a research note on Friday, February 23rd. Needham & Company LLC upped their price objective on shares of iRhythm Technologies from $136.00 to $137.00 and gave the stock a “buy” rating in a research report on Friday, February 23rd. Finally, Canaccord Genuity Group upped their price objective on shares of iRhythm Technologies from $121.00 to $133.00 and gave the stock a “buy” rating in a research report on Friday, February 23rd. One research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $135.11.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.